Liraglutide-A Novel GLP-1 Analogue

Title: Liraglutide-A Novel GLP-1 Analogue

Volume: 3 Issue: 3

Author(s): Sanjay Kalra, Bharti Kalra and Amit Sharma

Affiliation:

Keywords: Liraglutide, type 2 diabetes, incretins, glucagon like peptide-1 (GLP-1)

Abstract: Liraglutide is a novel glucagon-like peptide 1 analogue, which shows promise as a safe, effective therapy for type 2 diabetes. This review discusses the pathophysiology of type 2 diabetes, focusing on the incretin system, and reviews the pharmacology of liraglutide. A concise discussion of preclinical and clinical data is given, highlighting the benefits of liraglutide with respect to glycaemic control, weight modulation and extraglycaemic effects. This article also review some of recent patents related to the field.

Cite this article as:

Kalra Sanjay, Kalra Bharti and Sharma Amit, Liraglutide-A Novel GLP-1 Analogue, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) 2009; 3 (3) . https://dx.doi.org/10.2174/187221409789104719